Avraham Barak alleges that Teva's board and officers must have approved the criminal activity that led to the penalty. At the end of last week, Teva Pharmaceuticals Industries (TASE: TEVA; NYSE: TEVA) announced that it had reached a settlement with the US Department of Justice and would pay penalties totaling $450 million, payable over six years, without admitting wrongdoing, to end lawsuits brought against it by the US authorities.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile